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population are associated with the
development of multiple organ dysfunction
syndrome in trauma patients
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Abstract
Background: Early survival following severe injury has been improved with refined resuscitation strategies. Multiple
organ dysfunction syndrome (MODS) is common among this fragile group of patients leading to prolonged
hospital stay and late mortality. MODS after trauma is widely attributed to dysregulated inflammation but the
precise mechanics of this response and its influence on organ injury are incompletely understood. This study was
conducted to investigate the relationship between early lymphocyte responses and the development of MODS
during admission.
Methods: During a 24-month period, trauma patients were recruited from an urban major trauma centre to an
ongoing, observational cohort study. Admission blood samples were obtained within 2 h of injury and before
in-hospital intervention, including blood transfusion. The study population was predominantly male with a blunt
mechanism of injury. Lymphocyte subset populations including T helper, cytotoxic T cells, NK cells and γδ T cells
were identified using flow cytometry. Early cytokine release and lymphocyte count during the first 7 days of
admission were also examined.
Results: This study demonstrated that trauma patients who developed MODS had an increased population of NK
dim cells (MODS vs no MODS: 22 % vs 13 %, p < 0.01) and reduced γδ-low T cells (MODS vs no MODS: 0.02 (0.01–0.03)
vs 0.09 (0.06–0.12) × 10^9/L, p < 0.01) at admission. Critically injured patients who developed MODS (n = 27) had higher
interferon gamma (IFN-γ) concentrations at admission, compared with patients of matched injury severity and shock
(n = 60) who did not develop MODS (MODS vs no MODS: 4.1 (1.8–9.0) vs 1.0 (0.6–1.8) pg/ml, p = 0.01). Lymphopenia
was observed within 24 h of injury and was persistent in those who developed MODS. Patients with a lymphocyte
count of 0.5 × 109/L or less at 48 h, had a 45 % mortality rate.
Conclusions: This study provides evidence of lymphocyte activation within 2 h of injury, as demonstrated by increased
NK dim cells, reduced γδ-low T lymphocytes and high blood IFN-γ concentration. These changes are associated with
the development of MODS and lymphopenia. The study reveals new opportunities for investigation to characterise the
cellular response to trauma and examine its influence on recovery.
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Background
Refined resuscitation strategies have improved early sur-
vival for trauma patients [1–3]. Expediting recovery is
the next challenge for clinicians as mortality after 24 h
remains high and multiple organ dysfunction syndrome
(MODS) is a major contributing factor [4]. MODS inflicts
a substantial burden of acute and long-term morbidity
upon patients requiring prolonged intensive care unit
(ICU) admissions and high healthcare costs [5].
Development of MODS is widely attributed to an
uncontrolled immune system dysfunction, precipitated
by the release of damage-associated molecular patterns
(DAMPs) from extensive tissue damage and ischaemia
[6–8]. The systemic inflammatory response this gener-
ates is currently characterised by prolific release of inflam-
matory mediators and widespread genomic activation
[6, 9–11]. High levels of inflammation correlate with
worse outcomes, but the precise elements of the in-
flammatory process which lead to organ failure remain
unclear [12].
In recent years, certain lymphocyte subsets have been
identified as key components of the early, innate im-
mune response [13–15]. This follows the discovery that
they possess an intrinsic capacity for activation following
direct contact with DAMPs, therefore bypassing the
slower ‘adaptive’ response on which lymphocytes were
previously thought to be reliant [16–18]. Lymphope-
nia has also been associated with increased mortality
after trauma [19, 20]. Current evidence therefore sug-
gests that lymphocytes may play an important role in
the immunological response to trauma, although they
have not been well characterised in the early post-injury
phase.
The principal objective of this study was to describe
the lymphocyte phenotype in trauma patients immediately
on arrival to hospital and to assess the relationship with
MODS and lymphopenia during recovery. We conducted
a prospective observational cohort study at a single major
trauma centre (MTC).
Methods
Research setting and study participants
The Royal London Hospital is an urban major trauma
centre which has approximately 3000 full trauma team
activations each year. A prospective observational cohort
study called the ‘Activation of Coagulation and Inflamma-
tion after Trauma Study II’ (ACIT II) was established in
2008. Its purpose was to facilitate study of the biological
mechanisms responsible for acute traumatic coagulopathy
and the inflammatory response to trauma. It has ap-
proval from the National Health Service Research ethics
committee (REC: 07/Q0603/29). All patients requiring
full trauma team activation between 0800 and 2200 hours
were screened for eligibility. The exclusion criteria
included: age < 16 years, transfer from another hos-
pital, arrival > 120 minutes from injury, pre-hospital
administration of > 2000 ml crystalloid, > 5 % burns, se-
vere liver disease, known bleeding abnormality (including
anticoagulant medication), refused consent and vulnerable
patients. Consent for incapacitated patients was initially
obtained from a legally appointed representative in ac-
cordance with the Mental Health Act 2005 [21]. Written
consent was requested from all participants or next of kin
during the hospital stay.
Data collection
Blood was drawn into a 3-ml EDTA vacutainer (×2) and
a 4.5-ml citrated vacutainer (×2), within 10 minutes of
arrival at the MTC and < 2 h from injury. All samples
were taken before in-hospital interventions, such as
blood transfusion or surgical procedures. Interventions
prior to hospital arrival may have included intubation,
mechanical ventilation, thoracostomy and external frac-
ture splinting. Pre-hospital treatment protocols advocate
minimal use of crystalloid fluid (compound sodium lac-
tate [CSL]) except for patients in extremis. All interven-
tions and fluid administered during the resuscitation
phase were documented, in addition to demographic
data. Two further blood samples were drawn at 24 h
+/−1 h and on the day of 72 h. Whilst in critical care,
patients had a full blood count taken daily between 0400
and 0600 hours and additional samples at the discretion
of the clinical team. If patients had several blood tests
within a 24-h period, the most abnormal measurements
were recorded.
Outcome measurements
Patients were reviewed daily, until death or discharge.
The primary outcome measures were MODS and
lymphocyte count. MODS was defined as a Sequential
Organ Failure Score (SOFA) of 6 or more, on two or more
consecutive days, at least 48 h after admission [4, 22–24].
Secondary outcome measures included 28-day mortality
and the development of infection. Infection was defined
clinically using CDC criteria and was determined by con-
sensus between members of the research team (JM, EC)
[14, 15, 25].
Experiment methodology
Lymphocyte count
A differential white cell count was performed by the
hospital laboratory staff, using EDTA blood samples and
a Sysmex SE2100 Analyser (Sysmex, Milton Keynes, UK).
Normal range for our laboratory was 1.0–4.0 × 109/L and
lymphopenia was therefore defined as a lymphocyte
count < 1.0 × 10^9/L.
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Flow cytometry
Freshly drawn blood from an EDTA vacutainer was gen-
tly agitated to mix the contents, then 500 ul of whole
blood was withdrawn and placed in a falcon tube. Seven
millilitres of warmed (37 °C) BD lysis buffer (Cat No:
552052; BD, Oxford, UK) was added and the tube briefly
vortexed to achieve red cell lysis. The mixture was di-
luted with phosphate-buffered saline (PBS) and centri-
fuged at 200 g for 10 minutes. The supernatant was
discarded and the cellular pellet re-suspended in the re-
sidual fluid (approximately 200 ul). Fc blocker was added
and the tube incubated in the dark for 10 minutes at
room temperature (RT). Titrated volumes of colour-
labelled antibodies (eBioscience, San Diego, CA, USA)
were then added to the cell suspension: CD45 PerCP-
Cy5.5 (45–0459), CD3 PE-Cy7 (25–0038), CD4 eFluor
450 (48–0047), CD8 APC-eFluor 780 (47–0088), CD56
APC (17–0567), δγ TCR FITC (11–9959), and CD69 PE
(12–0699). The solution was incubated in the dark at RT
for 15 minutes. The cells were washed with 2 ml PBS
and centrifuged at 200 g for 5 minutes (×2). Then
samples were fixed with 4 % paraformaldehyde and
stored in the dark at 4 °C. Cytometer readings were
performed within 48 h using a BD Canto II flow cyt-
ometer. Lymphocytes were identified using CD45 and
side scatter.
ELISA
Citrated vacutainer blood samples were centrifuged at
3400 rpm for 10 minutes. The plasma supernatant was
then stored in aliquots at −80 °C. Plasma cytokine analysis
was performed using a Meso Scale SECTOR Imager 2400
and a 7-plex platform, in accordance with their standard
protocol (Meso Scale Discovery, Rockville, MD, USA).
Patient selection
The three reported experiments were performed sequen-
tially, using different patient cohorts. In all experiments,
patient injuries were characterised using the Injury Se-
verity Score (ISS) and base deficit (BD) at admission. BD
was used as a surrogate marker for haemorrhagic shock
[26, 27]. Control patients were also recruited. These
were patients who underwent full trauma team assessment
but were found to have no significant injuries, defined as
an ISS 0–2 and BD −2 to 2 mmol/L.
The inclusion criteria varied for each experiment. The
flow cytometry experiment was conducted with sequen-
tially recruited patients of all injury levels. The cytokine
experiment used specifically defined patient characteris-
tics, namely: a blunt mechanism of injury, ISS ≥ 25, <
500 ml CSL and no blood products prior to blood draw.
These patients were identified from the available ACIT
II database along with some controls. The criteria were
defined a priori with the intention of obtaining two
comparable groups, matched for injury severity and shock
but with different outcomes. In addition, we wished to ex-
clude the immunological influence of blood products [10].
The lymphocyte count experiment included patients ad-
mitted to the ICU to enable assessment of the significance
of the lymphocyte count in the patient population at risk
of MODS.
Data analysis and statistics
Data are presented as mean (95 % confidence interval
[CI]) and tested using Student’s t test or analysis of vari-
ance (ANOVA), unless otherwise stated. Mann-Whitney
U tests were used for non-parametric data and Fisher’s
exact test was used for categorical data. Cytokine con-
centrations were transformed into their natural log to
enable analysis with parametric tests. Survival was
assessed using a Kaplan-Meier analysis and a log-rank
test. Flow cytometry data was analysed using Flow Jo
Software version 10.6 (Treestar, Inc., Ashland, OR,
USA). Data analysis and statistics were performed using
GraphPad Prism 5.01 (GraphPad, Software, Inc., La Jolla,
CA, USA, Excel (Microsoft Corp., Redmond, WA, USA)
or IBM SPSS version 23 (IBM Corp., Armonk, NY,
USA). A p value of < 0.05 was considered statistically
significant.
Binary logistic regression was performed, using SPSS,
on the ICU cohort data (n = 280) to identify variables
that were independently associated with MODS develop-
ment. The variables entered included demographics, in-
jury characteristics and the lymphocyte count at 48 h.
Univariate analysis was conducted initially and variables
identified as significant with a p < 0.1 were then added
into a forwards likelihood-ratio stepwise regression with
significance set at p < 0.05 for inclusion and p > 0.1 for
removal. Goodness of fit was assessed using Hosmer-
Lemeshow, Cox and Snell and Nagelkerke tests. Model
variables were analysed for multicollinearity and no
interdependence between the entered variables was iden-
tified as tolerance statistics were above 0.1 and variance
inflation factors (VIF) were less than 10.
The 7-day trend of lymphocyte count was tested using
a two-way mixed ANOVA. Data were first transformed
in to their natural log to reduce variance as demon-
strated by Levene's test. Despite this, several of the key
assumptions required for a valid ANOVA were violated;
namely, normal distribution, homogeneity of variance
and sphericity. Simple main effects were therefore also
tested, at each time point, using general linear model
univariate analysis.
Results
This study was conducted over a 24-month period with
three separate patient cohorts. The demographics are
presented separately.
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Early changes in lymphocyte subpopulations are
associated with the development of MODS
Forty patients were sequentially enrolled for flow cytom-
etry analysis. No patient received blood products or
more than 500 ml of CSL prior to blood draw. The study
cohort included a control group (n = 9) and an injured
group (n = 31) (Table 1). Two patients died within 48 h
of injury and were excluded from the analysis. After
exclusion of dead cells and doublets, lymphocytes were
gated. Several lymphocyte subsets were examined in-
cluding: T helpers (CD3+ CD4+), cytotoxic T cells
(CD3+ CD8+), γδ T cells (CD3+ TCRγδ+) and natural
killer (NK) cells (CD3- CD56+) (Table 1, Fig. 1). Within
2 h of injury, patients who later developed MODS had a
higher proportion of NK cells in their peripheral blood
(MODS vs no MODS: 23 % vs 14 %, p < 0.01 (Table 1).
This increase was specifically attributable to a rise in the
NK dim cell population (MODS vs no MODS: 22 % vs
13 %, p < 0.01) with no significant change in NK bright
cells (Table 1, Fig. 2). Patients with a NK dim cell popula-
tion above 15 % at 2 h from injury were almost six times
more likely to develop MODS (OR 5.7 95 % CI (1.2–26.3),
p = 0.03) [14, 15]. The population of γδ-low T lympho-
cytes was also significantly smaller in patients who subse-
quently developed MODS (MODS vs no MODS: 0.02 vs
0.09 × 109/L, p < 0.01). Early activation of all cells was
Table 1 Demographics of flow cytometry cohort
Demographics Controls No MODS MODS p value
n 8 19 11 -
% male 100 83 77 0.38
Age‡ 32 (26–35) 35 (27–44) 34 (27–52) 0.71
ISS‡ 1 (1–2) 10 (9–18) 33 (25–50) <0.01
Base deficit (mmol/L)‡ −1.9 (−2.3 to −1.0) −0.5 (−1.4 to −1.6) 3.8 (2.4–7.9) <0.01
Time of sample from injury (mins)‡ 66 (60–78) 67 (54–75) 85 (70–95) 0.09
CSL pre-draw (ml)‡ 0 (0) 0 (0) 500 (0–500) <0.01
SBP on arrival (mmHg)‡ 140 (135–149) 139 (131–145) 109 (96–125) <0.01
Hospital length of stay (days)‡ 2 (1–3) 7 (3–14) 20 (8–39) 0.07
ICU length of stay (days)‡ 0 (0) 0 (0) 8 (2–13) <0.01
28-day mortality % (n) 0 (0) 0 (0) 31 <0.01
Percentage†
Lymphocytes 18 (12–24) 18 (12–23) 17 (8–27) 0.95
Total NK cells 16 (7–24) 14 (11–17) 23 (16–29) 0.02
NK bright 0.6 (0.2–1.0) 1.3 (0.4–2.2) 0.8 (0.4–1.1) 0.12
NK dim 15 (7–23) 13 (10–16) 22 (16–28) <0.01
Gamma delta high 0.7 (0.4–1.0) 1.4 (0.2–2.5) 1.8 (0.0–3.9) 0.86
Gamma delta low 2.1 (1.2–2.9) 4.0 (2.5–5.5) 0.9 (0.5–1.4) <0.01
T helpers 32 (26–38) 32 (28–36) 35 (29–41) 0.28
Cytotoxic T cells 23 (18–27) 28 (23–33) 21 (17–25) 0.16
Cell count × 109/L†
Lymphocytes 2.0 (1.3–3.2) 1.4 (0.4–5.1) 2.5 (1.7–3.6) 0.80
Total NK cells 0.2 (0.1–0.6) 0.5 (0.2–0.7) 0.6 (0.2–0.9) 0.14
NK bright 0.01 (0.01–0.02) 0.03 (0.01–0.05) 0.02 (0.01–0.03) 0.20
NK dim 0.2 (0.1–0.5) 0.4 (0.2–0.6) 0.5 (0.2–0.8) 0.12
Gamma delta high 0.01 (0.01–0.03) 0.04 (0.00–0.09) 0.06 (0.00–0.16) 0.73
Gamma delta low 0.03 (0.01–0.08) 0.09 (0.06–0.12) 0.02 (0.01–0.03) <0.01
T helpers 0.6 (0.4–0.8) 0.9 (0.7–1.1) 0.7 (0.5–0.9) 0.08
Cytotoxic T cells 0.4 (0.3–0.7) 0.8 (0.6–1.0) 0.5 (0.3–0.7) 0.46
p values compare no MODS vs MODS, using Student’s t test
MODS multiple organ dysfunction syndrome, ISS Injury Severity Score, CSL intravenous crystalloid fluid, SBP systolic blood pressure, ICU intensive care unit,
NK natural killer
‡Median (interquartile range)
†Mean (95 % confidence interval)
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examined using CD69 but no increased expression was
observed (data not shown). Changes in the lymphocyte
subpopulations, within 2 h of injury, were associated with
later development of MODS.
Cytokine levels indicate early innate lymphocyte
activation
A cohort of blunt polytrauma patients with an ISS ≥ 25
was identified from the ACIT II database and divided by
outcome (MODS n = 27, no MODS n = 60). No patient
had blood products or more than 500 ml of crystalloid
before blood draw. The two groups had comparable
levels of injury severity and shock (MODS vs no MODS:
ISS = 34 (29–39) vs 30 (27–38), p = 0.49; BD = 9 (2.5–9.7)
vs 3.1 (1.8–6.7) mmol/L, p = 0.06). Cytokine quantification
was performed on stored plasma from these patients.
All seven cytokines were elevated above control levels,
confirming systemic activation of inflammation in both
groups. Comparison between the two groups demon-
strated higher concentrations of interferon gamma (IFN-γ),
interleukin (IL)-1β and IL-8 in patients who developed
MODS (Fig. 3). Despite matched injury characteristics,
patients who developed MODS displayed a specific pattern
of increased inflammation at 2 h following injury.
Lymphopenia is associated with early innate lymphocyte
aberrations, MODS and mortality
Lymphocyte count during the first 7 days of admission
was examined in the flow cytometry cohort (n = 31). Pa-
tients who developed MODS were found to have a lower
lymphocyte count at 48 h than those who recovered
without MODS (Fig. 4a). Patients who developed lym-
phopenia by 48 h (count below 1.0 × 109/L) had higher
NK dim populations at admission compared with those
who maintained their lymphocyte count (Fig. 4b).
Lymphocyte count during the first 7 days was then
examined in a larger cohort. All patients in this cohort
(n = 280) were severely injured and admitted to the ICU,
33 % of these fulfilled the study definition of MODS
(Table 2). Patients in the MODS group, had elevated
SOFA scores at admission, median (interquartile range
[IQR]) of 10 (8–11) and scores remained high through-
out the first 96 h. Patients in the no MODS group had
elevated SOFA scores at admission median 9 (8–10) but
Fig. 1 Typical flow cytometry plots of control, no MODS and MODS patients in blood drawn < 2 h following injury. a-c demonstrate NK cells dim
and bright for CD56 and d-f demonstrate γδ T cell populations low and high for TCR receptor expression. Values shown are percentages of the
lymphocyte population. MODS multiple organ dysfunction syndrome
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rapidly recovered. All patients had a normal lymphocyte
count within 2 h of injury. By 24 h, the mean lympho-
cyte count had fallen below the normal range in the
MODS group (Fig. 4c). The difference was even more
pronounced at 48 h and continued to day 7. Lymphope-
nia, neutrophil, monocyte, eosinophil and basophil
counts were also examined but no difference between
MODS and no MODS patients was observed. Binary lo-
gistic regression analysis demonstrated that lymphocyte
count at 48 h, ISS and BD were independent predictors
of MODS development, lymphocyte count at 48 h being
the strongest (Table 3). Patients with lymphopenia at
48 h, had a higher mortality rate than those with a nor-
mal count (17 % vs 5 % p = 0.02). Furthermore, patients
with severe lymphopenia at 48 h (lymphocyte count ≤
0.5 × 109/L) had a mortality rate of 45 % compared with
only 6 % in those with a count above 0.5 × 109/L
(Fig. 4d).
Discussion
This study has examined circulating lymphocytes in
severely injured trauma patients and provides new evi-
dence to suggest that lymphocyte activity within the first
2 h following injury is related to the development of
MODS and lymphopenia. High NK dim and low γδ-
low T lymphocyte populations coupled with high
IFN-γ concentrations suggest that lymphocytes are
active in the immediate post-injury phase. The associ-
ation between high NK dim cells at admission and
lymphopenia at 48 h links early changes to later im-
mune incompetence and a strong association between
lymphopenia and the development of MODS has been
demonstrated for the first time. Taken together, these
findings implicate lymphocytes in the pathogenesis of
MODS and suggest that immunological events acti-
vated prior to hospital admission may influence
recovery.
Fig. 2 Changes in specific cell populations were associated with the development of MODS. a and c An elevated percentage of NK dim cells was
observed in patients who later developed MODS. b and d A reduced percentage population and absolute number of γδ-low T lymphocytes was
observed in patients who later developed MODS (Table 1). Data are presented as geometric mean (95 % CI), ‘C’ indicates the control population
and * denotes p < 0.05 when comparing MODS with no MODS using Student’s t test. MODS multiple organ dysfunction syndrome, NK natural killer
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Natural killer (NK) cells account for 10–15 % of the
circulating lymphocytes in humans and are fundamental
to the ‘innate’ immune response [15]. The logistical chal-
lenges of conducting trauma research mean that very
few studies have specifically examined immune cell pop-
ulations after injury and none have focused on the first
2 h. NK cell populations have previously been shown to
decrease within 24 h and later functional impairment
has also been described [28, 29]. The mechanisms be-
hind our observed rise immediately after trauma remain
unclear but NK cells are known to increase in circula-
tion in response to drivers such as catecholamines [30].
This may reflect rapid mobilisation from bone marrow
and other secondary lymphoid tissues, or expedited mat-
uration from bright to dim CD56 expression [14]. The
NK dim cell subset are considered to have a ‘cytotoxic’
phenotype, but their functional role during the early
post-injury response remains unclear [15, 31]. The IFN-γ
measured at 2 h is presumed to originate from NK cells as
they store preformed IFN-γ which can be rapidly released
after activation [32].
In contrast, γδ-low T lymphocytes are predominantly
tissue-resident and make up < 5 % of the circulating T
cell population in humans [33]. Their presence in blood,
likely reflects migration. They are regarded as cytopro-
tective, therefore the association between low concentra-
tions of these cells and the development of MODS is
novel and may be important [13, 34]. Only one previous
study has examined γδ T cells in human trauma patients
(n = 7); this reported a fall around 72 h, which was
attributed to apoptosis [35]. More recently, a murine
study has demonstrated that γδ T cells regulate immune
cell infiltration of lung tissue, which may influence
acute lung injury [36]. There are large gaps in our
understanding of the immediate post-injury cellular
immune response and detailed immunological studies at
this pivotal time period are required.
Lymphopenia after trauma has been associated with
mortality but the association with MODS is a new find-
ing. Although ISS and BD are highlighted in the regres-
sion analysis as key risk factors for MODS development,
the 48-h lymphocyte count is the strongest predictor of
the included variables. In addition, patients with a very
low lymphocyte count ≤ 0.5 × 109/L at 48 h have a mor-
tality rate of 45 %. This suggests that lymphocyte-related
events within the first 48 h are critical to recovery. Lym-
phopenia is widely attributed to infection-induced apop-
tosis but this study challenges that assumption as
lymphopenia developed within 24 h, several days before
the onset of clinical infection [19, 37–40]. Although not
currently considered to be of clinical relevance, this study
suggests that lymphocyte count at 48 h could be an early
indicator of poor prognosis. The findings strengthen the
evidence that lymphopenia may be involved in the
pathogenesis of adverse outcome and that restoration
of lymphocyte count may be essential to recovery [19].
Several limitations of this study are acknowledged,
principally that sequential experiments complicate data
Fig. 3 Cytokine concentrations demonstrate early activation of lymphocytes following critical injury. Cytokines were quantified in plasma drawn
at < 2 h following injury in trauma patients (n = 87) with critical injury severity (ISS≥ 25) and control patients (n = 39). Patients who developed
MODS (n = 27) had higher concentrations of IFN-γ, IL-1β and IL-8 when compared to critically injured patients who did not develop MODS
(n = 60). IFN-γ: 0.6 (0.4–0.9), 1.0 (0.6–1.8), 4.1 (1.8–9.0), p = 0.01. TNF-α: 3.3 (2.9–3.7), 5.2 (4.5–6.1), 5.7 (4.6–7.0), p = 0.54. IL-1β: 0.1 (0.0–0.1), 0.2
(0.1–0.4), 0.7 (0.3–1.9), p = 0.04. IL-6: 6.1 (4.2–8.8), 91.0 (60.8–136.2), 176.6 (106.1–294.1), p = 0.06. IL-8: 3.8 (3.2–4.5), 12 (9.1–15.9), 21.5 (14.8–31.2),
p = 0.02. IL-10: 3.6 (2.5–5.3), 41.4 (28.0–61.2), 66.2 (40.4–108.5), p = 0.17. IL-12 p70: 0.6 (0.3–1.1), 2.2 (1.2–3.9), 2.5 (0.9–6.8), p = 0.78. Data are presented as
C, no MODS, MODS, p value in pg/mL as geometric mean (95 % CI). *Denotes p < 0.05 using Student’s t test comparing no MODS and MODS. IFN-γ
interferon gamma, IL interleukin, MODS multiple organ dysfunction syndrome, TNF-α tumour necrosis factor alpha
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interpretation and a single patient cohort would have
been preferable. The flow cytometry cohort was small
(n = 40) and patients with worse outcomes were more
severely injured. Some of the observations may therefore
reflect injury severity. This is a common critique of
trauma research and future work will endeavour to ob-
tain larger, matched injury groups. In addition, although
a high percentage of NK dim cells was observed, the ab-
solute count was not significantly different and this is
also attributed to the small size of the study. MODS is
currently defined using organ scores; in accordance with
the study definition, MODS was not formally diagnosed
until after 96 h although SOFA scores were elevated
from admission. We acknowledge that it is impossible to
identify the precise onset of MODS using organ scores.
The 7-day lymphocyte data are influenced by survivor
bias. Finally, despite transformation, the lymphocyte
count data violated key assumptions required for a valid
two-way mixed ANOVA test. This was due to the stark
differences between the 2 h samples and subsequent
days. Significance was confirmed with valid tests at each
time point but this limitation is accepted.
Conclusions
This study has demonstrated that early lymphocyte
activity is related to the development of MODS and
lymphopenia. The observed increase in NK dim cells, re-
duction in δγ-low T cells and high IFN-γ concentration
at 2 h after injury, suggest that lymphocytes may be
more important to the immediate post-injury response
Fig. 4 Lymphopenia at 48 h was associated with MODS, high NK dim populations at admission and increased mortality. a Patients who
developed MODS (n = 11) were found to have a lower lymphocyte count at 48 h compared to those who did not develop MODS (n = 19).
No MODS = 1.3 (1.0–1.7) × 10^9/L, MODS = 0.8 (0.7–1.1) × 10^9/L, p = 0.01. Data are presented as median (IQR) and * denotes p < 0.05 using
Mann-Whitney U test. b Patients with lymphopenia at 48 h had a higher percentage of NK dim cells in their circulation at 2 h post injury (n = 31).
Lymphocyte count≥ 1.0 = NK dim 12 % (6–18), < 1.0 = NK dim 17 % (14–25), p < 0.01. Data are presented as median (IQR) and * denotes p < 0.05
using Mann-Whitney U test. c MODS patients had persistent lymphopenia throughout the first 6 days of admission. Daily lymphocyte count was
examined in a cohort of ICU patients with an ISS > 15 after blunt trauma (n = 280). All patients had a normal lymphocyte count at admission.
Patients who developed MODS had lymphocyte counts well below the normal range from 24 h to 120 h (D6). No MODS: 1.8 (1.6–2.0), 1.2 (1.1–1.2),
1.0 (1.0–1.1), 1.2 (1.1–1.3), 1.2 (1.2–1.3), 1.5 (1.4–1.6), 1.6 (1.4–1.7). MODS: 1.8 (1.4–2.1), 0.9 (0.8–1.0), 0.8 (0.7–0.8), 0.7 (0.7–0.8), 0.6 (0.6–0.7), 0.7 (0.7–0.8),
1.0 (0.9–1.1). Data are presented as mean (95 % CI), dotted line indicates the normal range. Statistical significance was tested using a two-way mixed
ANOVA on natural log data (p < 0.001). This was supported by testing for simple main effects using a general linear model univariate analysis at each
time point (2 h: p = 0.21, 24 h–144 h: p < 0.001, denoted by*). Data are presented in order 2 h–144 h: F (1278) = 1.65, 22.91, 30.90, 92.59, 202.84,
196.43, 48.74 and η2 = < 0.01, 0.08, 0.10, 0.25, 0.42, 0.41, 0.15. d Severe lymphopenia at 48 h was associated with a high mortality rate. Patients with a
lymphocyte count≤ 0.5 × 109/L had a 45 % mortality rate compared with 6 % in those with a count > 0.5 × 109/L, p < 0.001 using the Mantel-Cox test
(n = 280). MODS multiple organ dysfunction syndrome, NK natural killer
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than previously appreciated. Development of MODS
appears to be influenced by cellular events which are ini-
tiated prior to hospital arrival and orchestrated within
the first 48 h. The study highlights the need for detailed
examination of cellular responses in trauma patients,
particularly in the first few hours, and emphasises the
importance of well-characterised patient cohorts and
consistent sampling time points in order to characterise
this complex, dynamic response. The study opens up
new lines of investigation for trauma research and sug-
gests that there may be new opportunities for interven-
tion to expedite recovery.
Key messages
 Lymphocyte activity within 2 h of injury is
associated with the development of MODS and
lymphopenia after trauma.
 Development of MODS is associated with high NK
dim cells and low γδ-low T lymphocyte populations
at admission.
 Lymphopenia occurs within 24 h after severe injury
and persists in patients with MODS
 Patients with a lymphocyte count ≤ 0.5 × 109/L at
48 h had a 45 % mortality rate
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